Safety and cost analysis of early discharge following percutaneous coronary intervention for acute coronary syndrome in patients with diabetes mellitus. Issue 8 (August 2019)

• Record Type: Journal Article
• Authors: Li, Shihong; Li, Zhizhong; Hou, Xuejian; Sun, Junping; Kang, Lihui; Cheng, Yutong; Tao, Ying; Li, Zhao; Chen, Xuanzu; Zhang, Donghua; Yan, Xianliang; Wang, Su; Gao, Yulong; Wang, Qian; Lin, Yun; Yin, Chengqian; Zhang, Jingmei; Gao, Yun; Huang, Ji; Wu, Xiangyu; Li, Nan; Su, Wang; Liu, Honghong; Sun, Tao
• Is Part Of: Journal of international medical research. Volume 47:Issue 8(2019)
• Page Start: 3905
• Page End: 3917
• Publication Date: 2019-08
• Subjects: Diabetes mellitus -- safety and cost -- acute coronary syndrome -- percutaneous coronary intervention -- early discharge -- hospitalization; Medicine -- Periodicals; Pharmacology -- Periodicals; 610.5
• DOI: 10.1177/0300060519842777
• Languages: English
• ISSNs: 0300-0605

Abstract

Objective: To evaluate the safety and cost of early discharge compared with ordinary discharge in patients with diabetes mellitus (DM) following percutaneous coronary intervention (PCI) for acute coronary syndrome. Methods: We performed a retrospective analysis of prospectively collected data from 474 patients with DM who were discharged from hospital following PCI at a regional center between 2012 and 2015. Results: A total of 192 patients (40.5%) were included in the early discharge group and 282 patients (59.5%) were included in the ordinary group. Mortality and morbidity after PCI were recorded. Kaplan–Meier analysis showed similar prognosis between the two groups at 30 days and at 1 year after discharge. However, hospitalization expenses for the regular discharge group were significantly higher than those of the early discharge group (RMB65, 750 vs. RMB50, 983). Conclusion: Our findings demonstrate that early discharge of patients with DM following PCI for acute coronary syndrome is safe compared with ordinary discharge, and may reduce hospitalization costs.